Investor agreements and capitalization for psychedelic businesses

Last reviewed: August 2026 · Psychedelic law changes quickly — verify current status before relying on this page.

For founders of licensed psilocybin service centers and natural medicine healing centers who want to understand how to raise capital from outside investors — what legal structures are available, what securities law requires, how licensing constraints affect investor eligibility, and what investor agreements should cover.

The short answer

Raising outside capital for a psychedelic business involves the same securities law framework as raising capital for any private company — with two significant constraints specific to the psychedelic context. First, any person who takes an ownership interest in a licensed service center or healing center must satisfy OPS or DOR’s licensing eligibility requirements, including a background check. An investor who would be disqualifying under those requirements cannot hold an equity interest in the licensed entity. Second, psilocybin’s federal Schedule I status creates investor due diligence concerns — particularly around banking access, IRC § 280E tax treatment, and the inability to access standard financing — that any informed investor will raise before committing capital. A founder who understands these constraints before approaching investors is better positioned to structure a raise that closes.

Securities law: the core framework

When a founder offers an equity interest in their service center to an outside investor, that offer is almost certainly an offer of a security under federal law (Securities Act of 1933) and Oregon or Colorado state law. The default rule is that securities must be registered with the SEC unless an exemption applies. Registration is expensive and impractical for most early-stage psychedelic businesses. Founders raising outside capital almost always rely on an exemption.

The most commonly used federal exemption for private company capital raises is Regulation D under the Securities Act. Reg D offers two primary exemptions relevant to psychedelic businesses.

Rule 506(b) allows an issuer to raise an unlimited amount of capital from up to 35 non-accredited investors and an unlimited number of accredited investors, provided there is no general solicitation or advertising of the offering. Non-accredited investors under Rule 506(b) must receive substantial disclosure about the offering — the equivalent of a private placement memorandum — and the issuer must have a reasonable basis to believe they can evaluate the investment.

Rule 506(c) allows general solicitation and advertising of the offering but limits investors to verified accredited investors only. An accredited investor under federal law is generally an individual with net worth exceeding $1 million excluding primary residence, or annual income exceeding $200,000 ($300,000 jointly with a spouse), or certain professional certifications.

Both Reg D exemptions require the issuer to file a Form D notice with the SEC within 15 days of the first sale. Failure to file does not invalidate the exemption, but it is a compliance obligation. Oregon and Colorado have state securities laws — the Oregon Securities Law (ORS 59.005 et seq.) and the Colorado Securities Act (C.R.S. § 11-51-101 et seq.) — that require separate state filings or exemption compliance for offerings made to residents of those states.

Oregon’s intrastate crowdfunding exemption

Oregon provides a state-level crowdfunding exemption under ORS 59.035 for offerings up to $250,000 made exclusively to Oregon residents through a registered Oregon crowdfunding portal. This exemption does not require investors to be accredited and allows broader participation from the local community. For a service center founder who wants to raise modest amounts from a community of supporters — particularly for a mission-driven or equity-focused venture — the Oregon crowdfunding exemption may be appropriate. Colorado has a similar intrastate offering exemption under the Colorado Crowdfunding Act (C.R.S. § 11-51-308.5) for offerings up to $1 million to Colorado residents.

Licensing eligibility and investor due diligence

Before accepting any investment that involves an equity interest in the licensed service center entity, the founder must confirm that the proposed investor satisfies OPS’s or DOR’s licensing eligibility requirements. In Oregon, all persons with a financial interest in a licensed service center must be disclosed to OPS and must pass a background check under OAR 333-333. In Colorado, all persons with a direct or indirect financial interest above DOR’s specified threshold must be disclosed and pass DOR’s background check.

This means the investor diligence process runs in both directions. The founder evaluates the investor for fit and terms; OPS or DOR evaluates the investor for licensing eligibility. An investor who has a disqualifying criminal history — a conviction for a crime substantially related to the duties of a service center licensee under ORS 475A.477 — cannot hold an equity interest in the licensed entity regardless of how attractive their capital or strategic value might be. Accepting capital from an investor without first confirming their licensing eligibility can require a forced restructuring at the worst possible time — when the investment has already been received and the licensing issue surfaces in the background check.

The practical implication is that the investment documents should include a representation by the investor about their ability to satisfy background check requirements, a condition precedent to closing tied to background check clearance, and a buyout or transfer provision that addresses what happens if the investor is later found disqualifying.

What investors in psychedelic businesses need to understand

An investor conducting due diligence on a psychedelic service center will encounter a set of risk factors specific to this industry that are not present in most private company investments. A founder who addresses these proactively — in the private placement memorandum or investor presentation — moves through due diligence more efficiently than one who is caught off guard by investor questions.

Banking access limitations mean the business may not have standard banking relationships, and the investor’s capital may need to be deployed through alternative banking channels. This is not a red flag unique to the specific company — it is an industry-wide constraint — but investors unfamiliar with the space may treat it as one.

IRC § 280E applies to the business, meaning federal taxable income is substantially higher than economic income. Investors who are not familiar with § 280E may model returns based on after-expense income rather than after-§ 280E taxable income, which produces materially different projections.

Federal law risk — the possibility that federal enforcement priorities shift, that psilocybin scheduling changes, or that Congress acts to preempt state programs — is a background risk that cannot be fully quantified. Most investors in this space accept this risk as part of an emerging industry investment, but it should be disclosed clearly.

The licensing framework means the business cannot be transferred or sold without regulatory approval of the new ownership. An investor whose exit strategy involves a sale of the company must understand that the buyer must satisfy OPS or DOR licensing requirements and that regulatory approval will be required for the transfer.

Structure of the investor agreement

Most early-stage psychedelic business investments are structured as one of the following: a membership interest purchase agreement (if the entity is an LLC); a simple agreement for future equity (SAFE) or convertible note (if the raise is pre-revenue and valuation has not been established); or a preferred equity subscription agreement (if the entity has been valued and the investor is receiving preferred membership interests with specific rights).

Whatever the instrument, the investor agreement for a psychedelic business should address several provisions beyond those in a standard investment agreement.

Licensing eligibility representations — the investor represents that they satisfy applicable background check requirements and will cooperate with OPS or DOR background check processes.

Regulatory condition — closing is conditioned on background check clearance if the investment results in a disclosable ownership interest under licensing rules.

Drag-along and forced transfer — if the investor is later found disqualifying by OPS or DOR, the agreement should specify a mechanism for the investor to transfer their interest at a defined price, or for the company to repurchase it, to avoid a licensing problem that cannot otherwise be resolved.

Information rights — the investor’s right to financial information about the company, given the § 280E-adjusted tax treatment and the cash-intensive nature of the business, should be clearly defined.

Anti-dilution and pro-rata rights — standard investor protections that apply in any private equity context apply here as well.

Restrictions on transfer — membership interests in a licensed entity cannot be freely transferred without OPS or DOR notification and approval. Transfer restrictions in the operating agreement and the investor agreement must reflect this regulatory constraint.

The private placement memorandum

A Reg D Rule 506(b) offering to non-accredited investors requires substantial disclosure equivalent to a prospectus. Even for offerings limited to accredited investors, a private placement memorandum (PPM) is the standard disclosure document and provides the founder with a litigation defense — an investor who received full disclosure of the risk factors cannot later claim they were not informed.

The PPM for a psychedelic business should include, among other things: a description of the business and its licensing status; a description of the regulatory framework and the risks of regulatory action; disclosure of IRC § 280E and its effect on financial projections; disclosure of banking access limitations; disclosure of the federal law background and the risk that federal enforcement priorities could affect the business; disclosure of the licensing eligibility requirement for investors; and a full set of financial statements or projections.

A PPM that omits material information about the psychedelic regulatory context — § 280E, banking constraints, licensing eligibility requirements — is inadequate disclosure and creates securities fraud exposure for the founder regardless of whether any investor is actually harmed.

Investor relations and ongoing reporting

Once investors are in, the operator has ongoing obligations. Depending on the investment agreement’s terms, these typically include: periodic financial reporting (monthly, quarterly, or annual); notification of material events — license actions, regulatory investigations, significant client incidents, and changes in key personnel; and the right of major investors to inspect books and records.

A service center that goes through an OPS investigation or receives a notice of proposed license action has a material event to report to investors. Founders who delay reporting material events to investors — hoping to resolve the issue before disclosure — create both contractual liability and potential securities fraud exposure.

When public information may be enough

The Securities Act of 1933 and Regulation D are available at sec.gov. The Oregon Securities Law (ORS 59.005 et seq.) is at the Oregon Legislative Assembly. The Colorado Securities Act (C.R.S. § 11-51-101 et seq.) is at leg.colorado.gov. The SEC’s Form D instructions and filing system are at sec.gov/cgi-bin/browse-edgar. Oregon’s crowdfunding exemption (ORS 59.035) and Colorado’s crowdfunding statute (C.R.S. § 11-51-308.5) are publicly available.

When you should speak with a lawyer

A founder who is raising outside capital — at any amount, from any investor — should retain a securities attorney before soliciting any investment. The securities law framework is not forgiving of technical violations even where no investor is harmed. A founder who has already accepted capital without proper securities law compliance should consult a securities attorney about remediation options before the situation becomes an enforcement problem. An investor who has questions about the licensing eligibility requirement for a specific investment should consult both a securities attorney and an administrative licensing attorney familiar with OPS or DOR requirements.

You might also want to read

This article is for general informational purposes only and does not constitute legal advice. Securities law and psychedelic business licensing requirements change frequently. For advice specific to your capital raise, retain a licensed attorney with securities law and psychedelic business experience.